A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation (2017) Ott C, Jumar A, Striepe K, Friedrich S, Karg M, Bramlage P, Schmieder R Journal article Five-year clinical outcomes in patients with diabetes mellitus treated with polymer-free sirolimus- and probucol-eluting stents versus second-generation zotarolimus-eluting stents: A subgroup analysis of a randomized controlled trial (2016) Harada Y, Colleran R, Kufner S, Giacoppo D, Rheude T, Michel J, Cassese S, et al. Journal article Achievement of treatment goals for secondary prevention of myocardial infarction or stroke in 29,325 patients with type 2 diabetes: a German/Austrian DPV-multicenter analysis (2016) Bohn B, Schöfl C, Zimmer V, Hummel M, Heise N, Siegel E, Karges W, et al. Journal article Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes (2014) Ott C, Raff U, Schmidt S, Kistner I, Friedrich S, Bramlage P, Harazny JM, Schmieder R Journal article The role of co-morbidity in the selection of antidiabetic pharmacotherapy in type-2 diabetes (2013) Tschoepe D, Hanefeld M, Meier JJ, Gitt AK, Halle M, Bramlage P, Schumm-Draeger PM Journal article, Review article Vildagliptin in addition to metformin improves retinal blood flow and erythrocyte deformability in patients with type 2 diabetes mellitus - results from an exploratory study (2013) Berndt-Zipfel C, Michelson G, Dworak M, Mitry M, Loeffler A, Pfuetzner A, Forst T Journal article